Safety of the Blood Supply in Latin America
Open Access
- 1 January 2005
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 18 (1), 12-29
- https://doi.org/10.1128/cmr.18.1.12-29.2005
Abstract
SUMMARY: Appropriate selection of donors, use of sensitive screening tests, and the application of a mandatory quality assurance system are essential to maintain the safety of the blood supply. Laws, decrees, norms, and/or regulations covering most of these aspects of blood transfusion exist in 16 of the 17 countries in Latin America that are the subject of this review. In 17 countries, there is an information system that, although still incomplete (there are no official reports on adverse events and incidents), allows us to establish progress made on the status of the blood supply since 1993. Most advances originated in increased screening coverage for infectious diseases and better quality assurance. However, in 2001 to 2002, tainted blood may have caused infections in 12 of the 17 countries; no country reached the number of donors considered adequate, i.e., 5% of the population, to avoid blood shortages, or decreased significantly the number of blood banks, although larger blood banks are more efficient and take advantage of economies of scale. In those years, paid donors still existed in four countries and replacement donors made up >75% of the blood donors in another eight countries. In addition, countries did not report the number of voluntary donors who were repeat donors, i.e., the healthiest category. In spite of progress made, more improvements are needed.Keywords
This publication has 80 references indexed in Scilit:
- Viral diagnostics in the arena of blood donor screeningVox Sanguinis, 2004
- Haemovigilance around the worldVox Sanguinis, 2002
- Residual transfusion risk for hepatitis B and C in southern Brazil, 1991-99Journal of Viral Hepatitis, 2001
- Performance of second‐ and third‐generationRIBAs for confirmation of third‐generationHCV EIA‐reactive blood donationsTransfusion, 2000
- The Optimal Treatment for Haemophiliacs Who Have Developed Factor VIII or -IX AntibodiesVox Sanguinis, 2000
- An audit of appropriate use of blood products in adult patients in a Venezuelan general university hospitalInternational Journal for Quality in Health Care, 1999
- Haemovigilance SystemsVox Sanguinis, 1999
- Affordable safety for the blood supply in developed and developing countriesTransfusion Medicine, 1998
- Risk of exposure to Chagas' disease among seroreactive Brazilian blood donorsTransfusion, 1996
- Is the Apparent Outbreak of Hepatitis A in Belgian Hemophiliacs due to a Loss of Previous Passive Immunity?Vox Sanguinis, 1994